https://all-american-s3e7.8b.io/

A controversial herbal concoction has been in the news again in India, with renewed claims that it is effective against coronavirus.The substance, called Coronil, was launched recently at an event attended by some Indian government ministers.

But there is no evidence that it works, and misleading claims have been made about approval for its use.

Source link : https://all-american-s3e7.8b.io/

What do we know about the substance?

It's a combination of herbs used in traditional Indian medicine and sold by Patanjali, a big consumer goods company in India, under the name of Coronil.

It first appeared in June last year, promoted by popular yoga guru Baba Ramdev, and described - without any basis - as a "cure" for Covid-19.

But marketing had to stop after an intervention by the Indian government, which said there was no data to show it worked as a treatment.

However, the government said it could continue to be sold as "an immunity booster".

On 19 February this year, the company held another event - with Health Minister Dr Harsh Vardhan present - at which claims were repeated that it could prevent and treat Covid-19.

India's coronavirus health claims fact-checked

Fake 'Covid immunity booster' sold in shops

Dr Vardhan's presence attracted criticism from India's largest doctors' body, the Indian Medical Association.

They described the promotion of an "unscientific medicine" in the presence of the health minister as an "insult to the people of India", and asked the minister to clarify whether he supported it as a cure.

We contacted the health ministry to ask about Dr Vardhan's presence at the event, but had not received a response by the time of publication.

The Patanjali company defended the minister's attendance, saying "he neither endorsed ayurveda [India's traditional medicine], nor undermined modern medicine".

What are the claims made about Coronil?

The company continues to insist its product works against Covid-19.

"It has treated and cured people," Acharya Balkrishna, managing director of Patanjali told the BBC.

It referred us to scientific trials, the results of which it says have been published in several peer-reviewed journals.

It pointed specifically to a study from November 2020 in a journal published by the Swiss-based MDPI, which was based on a laboratory trial.